PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA. Electronic address: tande.aaron@mayo.edu.\', \'Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.\', \'Delta Air Lines, Atlanta, GA, USA.\', \'Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.\', \'Georgia Department of Health, Atlanta, GA, USA.\', \'Division of Health Care Delivery Research, Robert D. and Patricia E, Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.\', \'Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0025-6196(21)00644-310.1016/j.mayocp.2021.08.019
?:hasPublicationType
?:journal
  • Mayo Clinic proceedings
is ?:pmid of
?:pmid
?:pmid
  • 34736612
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.551
?:rankingScore_hIndex
  • 153
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Testing Before International Airline Travel, December 2020 to May 2021.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all